These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4617868)

  • 1. The relation of bioavailability to the dissolution rate of experimentally produced digoxin tablets.
    Johnson BF; Greer H; McCrerie JA; Bye C; Fowle AS
    Postgrad Med J; 1974 Nov; 50 Suppl 6():48-52. PubMed ID: 4617868
    [No Abstract]   [Full Text] [Related]  

  • 2. Digoxin tablets--a review of the bioavailability problems.
    Sim SK
    Am J Hosp Pharm; 1976 Jan; 33(1):44-8. PubMed ID: 1266866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate.
    Nyberg L; Andersson KE; Bertler A
    Acta Pharm Suec; 1974 Nov; 11(5):471-92. PubMed ID: 4440505
    [No Abstract]   [Full Text] [Related]  

  • 4. [Improved bioavailability of Israeli digoxin tablets with increased dissolution rates].
    Halkin H; Farfel Z; Saginer P; Millman P; Gibbor Y
    Harefuah; 1977 Oct; 93(7-8):189-91. PubMed ID: 924245
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers.
    Bansinath M; Ghosh SS; Shafiqa A; Shukla VK; Chopra KS; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):30-3. PubMed ID: 3957487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of digoxin from tablets. I. In vitro characterization of digoxin tablets.
    Nyberg L; Bratt L; Forsgren A; Hugosson S
    Acta Pharm Suec; 1974 Nov; 11(5):447-58. PubMed ID: 4440503
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioavailability of digoxin from tablets. IV. Urinary excretion of digoxin during multiple dose treatment.
    Nyberg L; Andersson KE; Fagerström PO
    Acta Pharm Suec; 1977; 14(2):119-36. PubMed ID: 906830
    [No Abstract]   [Full Text] [Related]  

  • 8. The biological availability of very rapidly dissolving digoxin tablets.
    Shaw TR; Raymond K; Greenwood H
    Postgrad Med J; 1974 Nov; 50 Suppl 6():55-9. PubMed ID: 4459890
    [No Abstract]   [Full Text] [Related]  

  • 9. The bioavailability of other digoxin preparations compared with tablets.
    Johnson BF; Bye C; Lader S
    Postgrad Med J; 1974 Nov; 50 Suppl 6():62-6. PubMed ID: 4459892
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
    Khan MK; Khan MF; Khan H; Mustafa G
    Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of digoxin in capsules.
    Padeletti L; Brat A
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):320-2. PubMed ID: 669878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rate of tetracycline dissolution from tablets and capsules and the biological availability of the antibiotic].
    Okhotnikova VF; Grakovskaia LK; Koroleva VG; Minasova GS; Zak IR
    Antibiotiki; 1976 Aug; 21(8):719-21. PubMed ID: 999252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between dissolution rate and bioavailability of paracetamol tablet.
    Huang XP; Wan XX; Liu Q
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):367-8, 371. PubMed ID: 12697478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of nalidixic acid from uncoated tablets in humans--Part I: Correlation with the dissolution rates of the tablets.
    Ogata H; Aoyagi N; Kaniwa K; Shibazaki T; Ejima A; Takasugi N; Mafune E; Hayashi T; Suwa K
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):175-83. PubMed ID: 6715086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of digoxin tablets in relation to their dissolution in vitro.
    Ylitalo P; Wilen G; Lundell S
    J Pharm Sci; 1975 Jul; 64(7):1264-6. PubMed ID: 1151696
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissolution properties of digoxin tablets marketed in the Republic of Ireland.
    Corrigan OI; Timoney RF
    Ir Med J; 1976 Feb; 69(3):60. PubMed ID: 1025046
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of particle size on the bioavailability of digoxin.
    Jounela AJ; Pentikäinen PJ; Sothmann A
    Eur J Clin Pharmacol; 1975 Jun; 8(5):365-70. PubMed ID: 1233237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical and dissolution characteristics and bio-availability of five brands of digoxin tablets.
    Fletcher S; Summers RS
    S Afr Med J; 1980 Apr; 57(14):530-3. PubMed ID: 7368019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalent bioavailability from digoxin elixir and rapid-dissolution tablets.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    JAMA; 1974 Sep; 229(13):1774-6. PubMed ID: 4479121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.